Click on the title of the presentations below to watch an archived video from the conference. Debate: Should Health Departments Stop Active Surveillance and Partner Services for Chlamydia? PRO Joan Chow, DrPH, MPH California Department of Public Health, CA CON William Miller, MD, PhD The Ohio State University, OH The Population-Level Impact of Screening Women […]
New Directions in Adolescent Risk What’s Different about Detroit’s School Screening Program? Research Aimed at Explaining Results Showing 5 Consecutive Years of Declines in CT Prevalence Detroit’s school-based STD screening program is the first such program to be associated with a sustained reduction in chlamydia prevalence. Richard Louis Dunville, MPH, Division of Adolescent and School […]
By John Papp, PhD Chlamydia and gonorrhea infections are common in non-genital sites in some populations such as men who have sex with men (MSM). Be-cause extra-genital infections are common in MSM and most infections are asymptomatic1, routine annual screening of extra-genital sites in MSM is recommended. No recommendations exist regarding routine extra-genital screening in […]
Commentary by Joan M. Chow, MPH, DrPH, Chief, Surveillance, Epidemiology, Assessment, and Evaluation Section, California Department of Public Health-Sexually Transmitted Disease Control Branch Although over 1.4 million chlamydia cases were reported to the Centers for Disease Control and Prevention (CDC) in 2013, there are potentially two to three times that number of infections as a […]
By Margaret R. Hammerschlag, MD The 2006 Centers for Disease Control and Prevention (CDC) STD Treatment Guidelines recommended that NAATs can be used to detect C. trachomatis in children being evaluated for suspected sexual abuse if culture is not available and if positive results can be confirmed1. Confirmation was specified as use of another NAAT […]
Men provide a reservoir for continued transmission of C. trachomatis to women, thus representing a population for potential targeted screening. There are no formal recommendations by professional organizations for screening men for chlamydia, however, guidance has been provided by the Centers for Disease Control and Prevention (CDC) for clinical sites wishing to screen men, who […]